441 - 450 of 8399 Results
Title
Year
-
OPENTitle: Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification TrialsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 11Start Page: 1345End Page: 1354Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14191Best OA location URL: https://doi.org/10.1002/mdc3.14191Citation Count: 0
-
OPENTitle: IAPP - oligomerisation levels in plasma of people with type 2 diabetesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-70255-3Citation Count: 0
-
OPENTitle: Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00763-6Citation Count: 7
- Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies2024OPENTitle: Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologiesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 385Issue #: 6711Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm6131Best OA location URL: https://doi.org/10.1101/2024.06.23.598940Citation Count: 21
-
OPENTitle: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficitsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 34Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adn6016Best OA location URL: https://doi.org/10.1126/sciadv.adn6016Citation Count: 8
-
OPENTitle: MRI subtypes in Parkinson’s disease across diverse populations and clustering approachesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00759-2Best OA location URL: https://doi.org/10.1038/s41531-024-00759-2Citation Count: 4
- Sleep duration in middle-aged years of life predicts the age of diagnosis of Parkinson's disease2024OPENTitle: Sleep duration in middle-aged years of life predicts the age of diagnosis of Parkinson's diseaseJournal Name: Sleep Medicine: XPublisher: Elsevier BVVol: 8Issue #:Start Page: 100123End Page: 100123Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.sleepx.2024.100123Citation Count: 1
-
OPENTitle: Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00747-3Best OA location URL: https://doi.org/10.1186/s13024-024-00747-3Citation Count: 9
-
OPENTitle: Loss-of-function variants in ITSN1 confer high risk of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00752-9Best OA location URL: https://doi.org/10.1038/s41531-024-00752-9Citation Count: 2
-
OPENTitle: The angiotensin (1–7) glycopeptide PNA5 improvescognition in achronic progressive mouse model of Parkinson's disease through modulation of neuroinflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 381Issue #:Start Page: 114926End Page: 114926Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114926Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114926Citation Count: 2